Shaun Holt

Shaun Holt serves as Chairman of the Board and Chief Executive Officer of Alveo Technologies. Previously, Shaun served as Chief Operating Officer of Atonarp, Inc, a Celesta Capital–backed optical- and mass-spectrometry instrumentation company. Prior to Atonarp, as Chief Financial Officer for Berkeley Lights, Inc, Shaun led the digital cell biology company through its $205 million initial public offering and held numerous finance leadership positions over his 7 years at Illumina during their exponential growth phases. He brings more than 20 years of operational and financial leadership experience across various technology and life sciences companies, from start-ups to large-capitalization companies. Shaun is an advisor to Celesta Capital and serves on the Board of Directors of Prellis Biologics.